Skip to content

Use of Analgesic Drugs in Renal Colic in Emergency Room

Use of Analgesic Drugs in Renal Colic in Emergency Room

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03278652
Acronym
NEPHROPAIN
Enrollment
60
Registered
2017-09-11
Start date
2016-04-19
Completion date
2017-12-31
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Colic

Brief summary

A prospective non-interventional study on the use of analgesic drugs in renal colic in emergency rooms

Interventions

OTHERConsumption of drugs for analgesic use

* Regular assessment of pain * Drug data will be collected (name, dosage, route of administration, time of delivery)

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than 18 years old * Suspicion of renal colic (pain in a lumbar pit radiating to the external genital organs, rapidly progressive onset, non-febrile)

Exclusion criteria

* Shock * Glasgow score less than 15 * Oxygen saturation less than 93% in ambient air * Signs of intracranial hypertension (headache associated with vomiting) * Suspicion of pneumothorax * History of emphysema or chronic obstructive pulmonary disease * Diving accident or suspicion of gas embolism * Trauma of the face of interest in the area of application of the mask * Abdominal gas distension * Contraindication in Nonsteroidal anti-inflammatory drugs * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Number of analgesic drug used in the context of renal colic in emergency rooms by following the recommended and validated service protocolDuring hospitalisation in emergency roomsCollection of name, dosage, route of administration, time of issue of the drug

Countries

France

Contacts

Primary ContactAlexandre Tanneau, MD
alexandre.tanneau@chu-rennes.fr02.99.28.60.48

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026